April 29th, 2013,
In: News By: admin
We are pleased to announce the launch the Medical Benchmark Center, powered by VCIQ in the PharmaTech newsletter. In addition to informative articles, featured products, and the latest research papers, we have added this benchmark center to continue to offer the most current and up-to-date information within the industry. ValueCentricIQ (VCIQ) is a healthcare intelligence … Read More
April 29th, 2013,
In: News By: admin
Pennsylvania Gov. Tom Corbett accepted the Biotechnology Industry Organization’s 2013 governor award for his work supporting the growth of the life science industry in the state. He was presented with the award at the biotech industry conference in Chicago Tuesday. Among the initiatives Corbett was credited with was his move in 2011 to assemble a … Read More
April 29th, 2013,
By: admin
Medidata Solutions Reports Record First Quarter 2013 Results Record revenues of $63.3 million, a 26% year-over-year increase Record application services revenue of $50.7 million, a 32% year-over-year increase Raises 2013 revenue guidance to between $270 and $274 million Medidata Solutions (NASDAQ: MDSO), the leading global provider of cloud-based solutions for the life sciences industry, today announced … Read More
April 23rd, 2013,
By: admin
Interphex 2013 is taking place in New York City from April 23-25. This event is showcasing exhibitors such as Bausch, Baxter, EMD Millipore Corporation, Reed-Lane, LB Bohle, Metrics Inc, AES Clean Technology, and Aphena Pharma Solutions. Then keynote sessions for Interphex 2013, include “Policy Recommendations for Imporvoing Patient Access to Drugs in Shortage” by Congressman … Read More
April 23rd, 2013,
By: admin
A small Cambridge biotech has inked three deals this year with major drug firms — Amgen, Pfizer and now AstraZeneca — which could net $1 billion for the maker of nanoparticles that promise to deliver drugs more efficiently to where they are needed in the body. “This is a clear indication that nanomedicine has reached … Read More
April 23rd, 2013,
By: admin
According to a new survey, life science professionals see large corporations and patent attorneys as the biggest beneficiaries of recent reforms that included a change to a first-to-file patent system. Of the 338 life science executives, researchers, academics and inventors, 41% said large corporations, regardless of location, will reap the most rewards from the act, … Read More
April 9th, 2013,
By: admin
Gov. Deval Patrick’s $1 billion investment plan for life science industries has added 2,537 jobs in its first five years, offering new opportunities for job growth in MetroWest and other regions around the state, a report released Tuesday says. “Our research suggests that the state will benefit from fully funding the remaining five years of … Read More
April 9th, 2013,
By: admin
Cold Chain IQ, a division of IQPC, announces the BioLogistics Summit, being held June 3-5, 2013 at the Golden Gateway Hotel in San Francisco, CA. This 2 track event will focus on maintaining a regulatory compliant transportation and management of biological materials, clinical specimens and infectious substances. Want better biologitics? What is the weakest link … Read More
April 9th, 2013,
By: admin
According to The Republic, an Indiana based publication, Bristol-Myers Squibb Co. will replace its top researcher with a physician and former medical school professor who has worked in pharmaceutical industry research for more than two decades. Dr. Francis Cuss, 58, will become the New York-based drugmaker’s executive vice president and chief scientific officer on July 1. … Read More
March 26th, 2013,
By: admin
Just about anyone who has gone to a pharmacy and paid for a prescription knows that a generic copy costs much less than the brand-name drug. The makers of those two versions of a drug, therefore, usually compete fiercely for market share and profits. But at the Supreme Court on Monday, the generic and the … Read More
